Hprt-targeted transgenes provide new insights into smooth muscle-restricted promoter activity

Ketrija Touw, April M. Hoggatt, Gina Simon, B. Herring

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Mouse telokin and SM22α promoters have previously been shown to direct smooth muscle cell-specific expression of transgenes in vivo in adult mice. However, the activity of these promoters is highly dependent on the integration site of the transgene. In the current study, we found that the ectopic expression of telokin promoter transgenes could be abolished by flanking the transgene with insulator elements from the H19 gene. However, the insulator elements did not increase the proportion of mouse lines that exhibited consistent, detectable levels of transgene expression. In contrast, when transgenes were targeted to the hprt locus, both telokin and SM22α promoters resulted in reproducible patterns and levels of transgene expression in all lines of mice examined. Telokin promoter transgene expression was restricted to smooth muscle tissues in adult and embryonic mice. As reported previously, SM22α transgenes were expressed at high levels specifically in arterial smooth muscle cells; however, in contrast to randomly integrated transgenes, the hprt-targeted SM22α transgenes were also expressed at high levels in smooth muscle cells in veins, bladder, and gallbladder. Using hprt-targeted transgenes, we further analyzed elements within the telokin promoter required for tissue specific activity in vivo. Analysis of these transgenes revealed that the CArG element in the telokin promoter is required for promoter activity in all tissues and that the CArG element and adjacent AT-rich region are sufficient to drive transgene expression in bladder but not intestinal smooth muscle cells.

Original languageEnglish
JournalAmerican Journal of Physiology - Cell Physiology
Volume292
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Transgenes
Smooth Muscle
Muscle
Insulator Elements
Cells
Tissue
Smooth Muscle Myocytes
AT Rich Sequence
telokin
Genes
Urinary Bladder
Gallbladder
Veins

Keywords

  • CArG element
  • Development
  • Embryos
  • Myosin light chain kinase
  • Visceral smooth muscle

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Hprt-targeted transgenes provide new insights into smooth muscle-restricted promoter activity. / Touw, Ketrija; Hoggatt, April M.; Simon, Gina; Herring, B.

In: American Journal of Physiology - Cell Physiology, Vol. 292, No. 3, 03.2007.

Research output: Contribution to journalArticle

Touw, Ketrija ; Hoggatt, April M. ; Simon, Gina ; Herring, B. / Hprt-targeted transgenes provide new insights into smooth muscle-restricted promoter activity. In: American Journal of Physiology - Cell Physiology. 2007 ; Vol. 292, No. 3.
@article{7ed9321154ee49e7bedb036325a40d90,
title = "Hprt-targeted transgenes provide new insights into smooth muscle-restricted promoter activity",
abstract = "Mouse telokin and SM22α promoters have previously been shown to direct smooth muscle cell-specific expression of transgenes in vivo in adult mice. However, the activity of these promoters is highly dependent on the integration site of the transgene. In the current study, we found that the ectopic expression of telokin promoter transgenes could be abolished by flanking the transgene with insulator elements from the H19 gene. However, the insulator elements did not increase the proportion of mouse lines that exhibited consistent, detectable levels of transgene expression. In contrast, when transgenes were targeted to the hprt locus, both telokin and SM22α promoters resulted in reproducible patterns and levels of transgene expression in all lines of mice examined. Telokin promoter transgene expression was restricted to smooth muscle tissues in adult and embryonic mice. As reported previously, SM22α transgenes were expressed at high levels specifically in arterial smooth muscle cells; however, in contrast to randomly integrated transgenes, the hprt-targeted SM22α transgenes were also expressed at high levels in smooth muscle cells in veins, bladder, and gallbladder. Using hprt-targeted transgenes, we further analyzed elements within the telokin promoter required for tissue specific activity in vivo. Analysis of these transgenes revealed that the CArG element in the telokin promoter is required for promoter activity in all tissues and that the CArG element and adjacent AT-rich region are sufficient to drive transgene expression in bladder but not intestinal smooth muscle cells.",
keywords = "CArG element, Development, Embryos, Myosin light chain kinase, Visceral smooth muscle",
author = "Ketrija Touw and Hoggatt, {April M.} and Gina Simon and B. Herring",
year = "2007",
month = "3",
doi = "10.1152/ajpcell.00445.2006",
language = "English",
volume = "292",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Hprt-targeted transgenes provide new insights into smooth muscle-restricted promoter activity

AU - Touw, Ketrija

AU - Hoggatt, April M.

AU - Simon, Gina

AU - Herring, B.

PY - 2007/3

Y1 - 2007/3

N2 - Mouse telokin and SM22α promoters have previously been shown to direct smooth muscle cell-specific expression of transgenes in vivo in adult mice. However, the activity of these promoters is highly dependent on the integration site of the transgene. In the current study, we found that the ectopic expression of telokin promoter transgenes could be abolished by flanking the transgene with insulator elements from the H19 gene. However, the insulator elements did not increase the proportion of mouse lines that exhibited consistent, detectable levels of transgene expression. In contrast, when transgenes were targeted to the hprt locus, both telokin and SM22α promoters resulted in reproducible patterns and levels of transgene expression in all lines of mice examined. Telokin promoter transgene expression was restricted to smooth muscle tissues in adult and embryonic mice. As reported previously, SM22α transgenes were expressed at high levels specifically in arterial smooth muscle cells; however, in contrast to randomly integrated transgenes, the hprt-targeted SM22α transgenes were also expressed at high levels in smooth muscle cells in veins, bladder, and gallbladder. Using hprt-targeted transgenes, we further analyzed elements within the telokin promoter required for tissue specific activity in vivo. Analysis of these transgenes revealed that the CArG element in the telokin promoter is required for promoter activity in all tissues and that the CArG element and adjacent AT-rich region are sufficient to drive transgene expression in bladder but not intestinal smooth muscle cells.

AB - Mouse telokin and SM22α promoters have previously been shown to direct smooth muscle cell-specific expression of transgenes in vivo in adult mice. However, the activity of these promoters is highly dependent on the integration site of the transgene. In the current study, we found that the ectopic expression of telokin promoter transgenes could be abolished by flanking the transgene with insulator elements from the H19 gene. However, the insulator elements did not increase the proportion of mouse lines that exhibited consistent, detectable levels of transgene expression. In contrast, when transgenes were targeted to the hprt locus, both telokin and SM22α promoters resulted in reproducible patterns and levels of transgene expression in all lines of mice examined. Telokin promoter transgene expression was restricted to smooth muscle tissues in adult and embryonic mice. As reported previously, SM22α transgenes were expressed at high levels specifically in arterial smooth muscle cells; however, in contrast to randomly integrated transgenes, the hprt-targeted SM22α transgenes were also expressed at high levels in smooth muscle cells in veins, bladder, and gallbladder. Using hprt-targeted transgenes, we further analyzed elements within the telokin promoter required for tissue specific activity in vivo. Analysis of these transgenes revealed that the CArG element in the telokin promoter is required for promoter activity in all tissues and that the CArG element and adjacent AT-rich region are sufficient to drive transgene expression in bladder but not intestinal smooth muscle cells.

KW - CArG element

KW - Development

KW - Embryos

KW - Myosin light chain kinase

KW - Visceral smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=33947302559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947302559&partnerID=8YFLogxK

U2 - 10.1152/ajpcell.00445.2006

DO - 10.1152/ajpcell.00445.2006

M3 - Article

C2 - 17079332

AN - SCOPUS:33947302559

VL - 292

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 3

ER -